Looking Ahead As Wegovys removal from the shortage list becomes official, expect: Heavy Crackdown on Compounders: Manufacturers and regulators will likely move quickly to shut down operations found selling compounded forms that mimic FDA-approved products
Good information Something went wrong
Consider risks and benefits of therapy in patients at risk for heart failure (e.g., history of heart failure or renal impairment)
The myotendinous junction studies (Japjec et al., 2021, Biomedicines ) extended the tendon work to the muscle-tendon interface, showing accelerated healing of disabled junctions in rats
Campilho A, Lilay GH, Benvindo M et al (2025) Expression patterns of Arabidopsis bZIP19 and bZIP23 elucidate their individual contribution to the regulation of the Zn deficiency response
The break trial represents valuable experiment for any GHK-Cu user completing 6+ month treatment course - discontinuing for 2-3 months reveals how well benefits persist, helps determine whether cycling or continuous use better suits individual biology, provides psychological break from rigid routine, and offers cost savings period while assessing necessity of ongoing application
